Azienda Ospedaliera San Giovanni Addolorata

Roma RM 00184

1 studies enrolling now · 9 studies all time

What they study most

Acute Chest Pain, Colorectal Cancer (CRC), Coronary Artery Disease (CAD), Extensive Stage Small-cell Lung Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, HIV Infections, Hypoparathyroidism, NSTEMI - Non-ST Segment Elevation MI, Small Cell Lung Cancer (SCLC), Small-cell Lung Cancer

Studies at this site

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation — Completed
• A Registry for Participants With Chronic Hypoparathyroidism — Completed
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
• A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC — Running, not enrolling
• Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI) — Running, not enrolling
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling
• Imaging of Coronary Plaques in Participants Treated With Evolocumab — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed